At ADA 2026, experts explored how GLP-1 receptor agonists are reshaping treatment for obesity, osteo...
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
At ADA 2026, experts explored how GLP-1 receptor agonists are reshaping treatment for obesity, osteoarthritis, nutrition, and muscle preservation.
Author: AJMC
Read Original Article